NDC 63833-825

Berinert

Human C1-esterase Inhibitor

Berinert is a Kit in the Plasma Derivative category. It is labeled and distributed by Csl Behring Gmbh. The primary component is .

Product ID63833-825_06798e0f-2295-4500-8cff-89f86deb6c64
NDC63833-825
Product TypePlasma Derivative
Proprietary NameBerinert
Generic NameHuman C1-esterase Inhibitor
Dosage FormKit
Marketing Start Date2011-12-22
Marketing CategoryBLA / BLA
Application NumberBLA125287
Labeler NameCSL Behring GmbH
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 63833-825-02

1 KIT in 1 CARTON (63833-825-02) * 10 mL in 1 VIAL (63833-835-01) * 10 mL in 1 VIAL (63833-765-15)
Marketing Start Date2011-12-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63833-825-02 [63833082502]

Berinert KIT
Marketing CategoryBLA
Application NumberBLA125287
Product TypePLASMA DERIVATIVE
Billing UnitEA
Marketing Start Date2011-12-22

Drug Details

NDC Crossover Matching brand name "Berinert" or generic name "Human C1-esterase Inhibitor"

NDCBrand NameGeneric Name
63833-825BerinertHUMAN C1-ESTERASE INHIBITOR
42227-081CinryzeHUMAN C1-ESTERASE INHIBITOR
42227-083CinryzeHUMAN C1-ESTERASE INHIBITOR
63833-828HAEGARDAHUMAN C1-ESTERASE INHIBITOR
63833-829HAEGARDAHUMAN C1-ESTERASE INHIBITOR

Trademark Results [Berinert]

Mark Image

Registration | Serial
Company
Trademark
Application Date
BERINERT
BERINERT
76045453 2613930 Live/Registered
CSL BEHRING GMBH
2000-05-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.